Cost of medication overuse headache in Italian patients at the time-point of withdrawal: a retrospective study based on real data

Domenico D’Amico, Licia Grazzi, Marcella Curone, Matilde Leonardi, Alberto Raggi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The objective was to assess the cost of Medication Overuse Headache (MOH) at the time-point of withdrawal treatment. We implemented a protocol in which both direct and indirect cost were directly gathered from patients and referred to the previous three months. Direct costs were calculated by medications for acute treatment and prophylaxis, diagnostic procedures, visits, complementary treatments, informal care. Indirect costs were referred to missed workdays and workdays with reduced productivity: we asked patients to refer their salaries and to rate the overall level of performance in days worked with reduced productivity, and we calculated indirect costs on this basis. A total of 135 patients were enrolled: direct costs were around 415€/month; indirect costs were 530€/month, and were mostly due to presenteeism (350€, 66.3%) rather than to absenteeism (160€, 33.7%). Our data showed higher cost than those of a previous study: this is likely due to a different approach to cost definition, to the inclusion of direct non-medical cost, and of non-pharmacological treatments.

Original languageEnglish
Pages (from-to)3-6
Number of pages4
JournalNeurological Sciences
Volume38
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Secondary Headache Disorders
Retrospective Studies
Costs and Cost Analysis
Efficiency
Absenteeism
Salaries and Fringe Benefits
Therapeutics

Keywords

  • Chronic migraine
  • Cost of disease
  • Medication overuse
  • Withdrawal

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Cost of medication overuse headache in Italian patients at the time-point of withdrawal : a retrospective study based on real data. / D’Amico, Domenico; Grazzi, Licia; Curone, Marcella; Leonardi, Matilde; Raggi, Alberto.

In: Neurological Sciences, Vol. 38, 01.05.2017, p. 3-6.

Research output: Contribution to journalArticle

@article{074a943fa4ec4a2b837feb90b3d8fe00,
title = "Cost of medication overuse headache in Italian patients at the time-point of withdrawal: a retrospective study based on real data",
abstract = "The objective was to assess the cost of Medication Overuse Headache (MOH) at the time-point of withdrawal treatment. We implemented a protocol in which both direct and indirect cost were directly gathered from patients and referred to the previous three months. Direct costs were calculated by medications for acute treatment and prophylaxis, diagnostic procedures, visits, complementary treatments, informal care. Indirect costs were referred to missed workdays and workdays with reduced productivity: we asked patients to refer their salaries and to rate the overall level of performance in days worked with reduced productivity, and we calculated indirect costs on this basis. A total of 135 patients were enrolled: direct costs were around 415€/month; indirect costs were 530€/month, and were mostly due to presenteeism (350€, 66.3{\%}) rather than to absenteeism (160€, 33.7{\%}). Our data showed higher cost than those of a previous study: this is likely due to a different approach to cost definition, to the inclusion of direct non-medical cost, and of non-pharmacological treatments.",
keywords = "Chronic migraine, Cost of disease, Medication overuse, Withdrawal",
author = "Domenico D’Amico and Licia Grazzi and Marcella Curone and Matilde Leonardi and Alberto Raggi",
year = "2017",
month = "5",
day = "1",
doi = "10.1007/s10072-017-2891-z",
language = "English",
volume = "38",
pages = "3--6",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - JOUR

T1 - Cost of medication overuse headache in Italian patients at the time-point of withdrawal

T2 - a retrospective study based on real data

AU - D’Amico, Domenico

AU - Grazzi, Licia

AU - Curone, Marcella

AU - Leonardi, Matilde

AU - Raggi, Alberto

PY - 2017/5/1

Y1 - 2017/5/1

N2 - The objective was to assess the cost of Medication Overuse Headache (MOH) at the time-point of withdrawal treatment. We implemented a protocol in which both direct and indirect cost were directly gathered from patients and referred to the previous three months. Direct costs were calculated by medications for acute treatment and prophylaxis, diagnostic procedures, visits, complementary treatments, informal care. Indirect costs were referred to missed workdays and workdays with reduced productivity: we asked patients to refer their salaries and to rate the overall level of performance in days worked with reduced productivity, and we calculated indirect costs on this basis. A total of 135 patients were enrolled: direct costs were around 415€/month; indirect costs were 530€/month, and were mostly due to presenteeism (350€, 66.3%) rather than to absenteeism (160€, 33.7%). Our data showed higher cost than those of a previous study: this is likely due to a different approach to cost definition, to the inclusion of direct non-medical cost, and of non-pharmacological treatments.

AB - The objective was to assess the cost of Medication Overuse Headache (MOH) at the time-point of withdrawal treatment. We implemented a protocol in which both direct and indirect cost were directly gathered from patients and referred to the previous three months. Direct costs were calculated by medications for acute treatment and prophylaxis, diagnostic procedures, visits, complementary treatments, informal care. Indirect costs were referred to missed workdays and workdays with reduced productivity: we asked patients to refer their salaries and to rate the overall level of performance in days worked with reduced productivity, and we calculated indirect costs on this basis. A total of 135 patients were enrolled: direct costs were around 415€/month; indirect costs were 530€/month, and were mostly due to presenteeism (350€, 66.3%) rather than to absenteeism (160€, 33.7%). Our data showed higher cost than those of a previous study: this is likely due to a different approach to cost definition, to the inclusion of direct non-medical cost, and of non-pharmacological treatments.

KW - Chronic migraine

KW - Cost of disease

KW - Medication overuse

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=85019571612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019571612&partnerID=8YFLogxK

U2 - 10.1007/s10072-017-2891-z

DO - 10.1007/s10072-017-2891-z

M3 - Article

AN - SCOPUS:85019571612

VL - 38

SP - 3

EP - 6

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

ER -